Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041129 · ClinicalTrials.gov registry record
Post-Prandial Liver Glucose Metabolism in PCOS
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 19
- Enrollment target
NCT03041129: Completed study, sponsored by University of Colorado, Denver.
NCT03041129 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03041129 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The Investigators will measure if hepatic metabolism is upregulated in obese girls with PCOS and hepatic steatosis (HS), compared to PCOS without HS and obese controls without HS.
Primary Outcome
Amount of fat in the liver measured by MRI and calculated via the Dixon method as the proton density hepatic fat fraction, which ranges from 0-75%. Greater than 5% is considered extra fat in the liver.
Interventions
- DIAGNOSTIC_TEST oral glucose tolerance test
- DIAGNOSTIC_TEST MRI of liver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2018-09-29 |
What the finished NCT03041129 record still lists
NCT03041129 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which oral glucose tolerance test is the first listed.
NCT03041129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03041129 about?
NCT03041129 is a clinical study titled "Post-Prandial Liver Glucose Metabolism in PCOS". The Investigators will measure if hepatic metabolism is upregulated in obese girls with PCOS and hepatic steatosis (HS), compared to PCOS without HS and obese controls without HS.
What is the current status of trial NCT03041129?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-04-14. Estimated completion is 2018-09-29.
What interventions are being tested in trial NCT03041129?
The interventions under investigation include: oral glucose tolerance test (DIAGNOSTIC_TEST), MRI of liver (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03041129?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI